Methyl 7-(dibenzylamino)-2-[2-fluoro-3-(triazol-2-yl)phenyl]-1H-pyrrolo[2,3-c]pyridine-4-carboxylate
C31H25FN6O2 — CID 146634513
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl 7-(dibenzylamino)-2-[2-fluoro-3-(triazol-2-yl)phenyl]-1H-pyrrolo[2,3-c]pyridine-4-carboxylate
Methyl 7-(dibenzylamino)-2-[2-fluoro-3-(triazol-2-yl)phenyl]-1H-pyrrolo[2,3-c]pyridine-4-carboxylate (PubChem CID 146634513) has the molecular formula C31H25FN6O2 and a molecular weight of 532.58 g/mol. Its IUPAC name is methyl 7-(dibenzylamino)-2-[2-fluoro-3-(triazol-2-yl)phenyl]-1H-pyrrolo[2,3-c]pyridine-4-carboxylate.
Molecular Properties
| Compound Name | Methyl 7-(dibenzylamino)-2-[2-fluoro-3-(triazol-2-yl)phenyl]-1H-pyrrolo[2,3-c]pyridine-4-carboxylate |
|---|---|
| PubChem CID | 146634513 |
| Molecular Formula | C31H25FN6O2 |
| Molecular Weight | 532.58 g/mol |
| Exact Mass | 532.20 |
| IUPAC Name | methyl 7-(dibenzylamino)-2-[2-fluoro-3-(triazol-2-yl)phenyl]-1H-pyrrolo[2,3-c]pyridine-4-carboxylate |
| SMILES | COC(=O)c1cnc(N(Cc2ccccc2)Cc2ccccc2)c2[nH]c(-c3cccc(-n4nccn4)c3F)cc12 |
| InChI | InChI=1S/C31H25FN6O2/c1-40-31(39)25-18-33-30(37(19-21-9-4-2-5-10-21)20-22-11-6-3-7-12-22)29-24(25)17-26(36-29)23-13-8-14-27(28(23)32)38-34-15-16-35-38/h2-18,36H,19-20H2,1H3 |
| InChIKey | MOFCJQVZMLYPHQ-UHFFFAOYSA-N |
| XLogP | 5.94 |
| TPSA | 88.93 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 40 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 532.58 |
| LogP ≤ 5 | 5.94 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 146634513 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.